Is preoperative CT-guided biopsy a valuable tool in the diagnostic workup of patients with visceral and retroperitoneal sarcoma?

[1]  A. B. Hassan,et al.  Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  John E. Mullinax,et al.  Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group , 2021, Annals of Surgical Oncology.

[3]  S. Kõks,et al.  Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma , 2021, Molecular Biology Reports.

[4]  S. Hendry,et al.  The role of 18F‐FDG PET/CT in retroperitoneal sarcomas—A multicenter retrospective study , 2021, Journal of surgical oncology.

[5]  C. Raut,et al.  Defining the role of neoadjuvant systemic therapy in high‐risk retroperitoneal sarcoma: A multi‐institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group , 2020, Cancer.

[6]  A. D. Dei Tos,et al.  The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives , 2020, Pathologica.

[7]  J. Hodson,et al.  Improved Biopsy Accuracy in Retroperitoneal Dedifferentiated Liposarcoma , 2020, Annals of Surgical Oncology.

[8]  M. Ghadimi.  Individualisierte multimodale Therapie retroperitonealer Weichteilsarkome , 2020, Zentralblatt für Chirurgie.

[9]  J. Hodson,et al.  Diagnostic accuracy of percutaneous biopsy in retroperitoneal sarcoma , 2019, British Journal of Surgery.

[10]  E. Keung,et al.  The clinical behavior of well differentiated liposarcoma can be extremely variable: A retrospective cohort study at a major sarcoma center , 2018, Journal of surgical oncology.

[11]  Rene Berindoague Neto,et al.  Clinical complications in renal biopsy using two different needle gauges: The impact of large hematomas, a random clinical trial study , 2018, International journal of urology : official journal of the Japanese Urological Association.

[12]  A. Lazar,et al.  Role of chemotherapy in dedifferentiated liposarcoma of the retroperitoneum: defining the benefit and challenges of the standard , 2017, Scientific Reports.

[13]  A. Gronchi,et al.  Neoadjuvant chemotherapy in soft tissue sarcomas: latest evidence and clinical implications , 2017, Therapeutic advances in medical oncology.

[14]  I. Judson,et al.  UK guidelines for the management of soft tissue sarcomas , 2016, Clinical Sarcoma Research.

[15]  K. Hunt,et al.  Accuracy of Preoperative Percutaneous Biopsy for the Diagnosis of Retroperitoneal Liposarcoma Subtypes , 2015, Annals of Surgical Oncology.

[16]  Clara C. Chen,et al.  Epidemiology, Treatment Patterns, and Outcomes of Metastatic Soft Tissue Sarcoma in a Community-Based Oncology Network , 2014, Sarcoma.

[17]  J. Blay,et al.  Advanced well-differentiated/dedifferentiated liposarcomas: role of chemotherapy and survival. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  S. Singer,et al.  Clinical and molecular approaches to well differentiated and dedifferentiated liposarcoma , 2011, Current opinion in oncology.

[19]  C. Creighton,et al.  Diagnosis, Management, and Outcome of Patients with Dedifferentiated Liposarcoma Systemic Metastasis , 2011, Annals of Surgical Oncology.

[20]  L. Mariani,et al.  Aggressive Surgery in Retroperitoneal Soft Tissue Sarcoma Carried Out at High-Volume Centers is Safe and is Associated With Improved Local Control , 2010, Annals of Surgical Oncology.

[21]  S. Sleijfer,et al.  Soft tissue sarcomas: ESMO clinical recommendations for diagnosis, treatment and follow-up. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[22]  F. van Coevorden,et al.  Long-term prognosis of primary retroperitoneal soft tissue sarcoma. , 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[23]  C. Raut,et al.  Retroperitoneal sarcomas: Combined‐modality treatment approaches , 2002, Journal of surgical oncology.

[24]  W. Mendenhall,et al.  Retroperitoneal soft tissue sarcoma , 2005, Cancer.

[25]  J. Manola,et al.  Liposarcoma subtypes: identification with computed tomography and ultrasound-guided percutaneous needle biopsy , 2005, European Radiology.

[26]  Samuel Singer,et al.  Histologic Subtype and Margin of Resection Predict Pattern of Recurrence and Survival for Retroperitoneal Liposarcoma , 2003, Annals of surgery.